Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab Concentrations

Ryan C. Ungaro, Jean Frederic Colombel, Marla C. Dubinsky, Anjali Jain, Thierry Dervieux,

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish
Pages (from-to)649-651
Number of pages3
JournalInflammatory Bowel Diseases
Issue number4
StatePublished - 1 Apr 2022


  • drug monitoring
  • immunogenicity
  • infliximab
  • thiopurine

Cite this